Making the Move to AAV producer cell lines: comparability, bridging studies and regulatory considerations

Lauren Coyle (Editor, BioInsights) speaks with Lonza's Laura Sands (Head of Regulatory Affairs), Ramesh Koukuntla (Director of R&D), Wenling Dong (Head of Upstream Process Development), and Vijetha Bhat (Subject Expert of Platform Technologies) about:

• Key regulatory considerations when transitioning to AAV producer cell lines 
• Comparability and bridging strategies to support a successful transition 
• Approaches to managing manufacturing and regulatory risk 
• Considerations for enabling scalable AAV production